What people are stacking right now

People run this after an injury that is not resolving. BPC-157 is the one reached for with tendon, ligament and gut problems, and TB-500 for broader soft tissue and getting range of motion back. The logic is that they work on repair from two different directions: BPC-157 is associated with building blood vessels into damaged tissue, TB-500 with getting repair cells to move where they are needed. Supply and delivery. It is the most discussed recovery combination in the category and the one most often sold premixed.

Wolverine with a copper peptide added, run by people who want the repair effect where it shows. GHK-Cu is the skincare ingredient used to smooth fine lines, fade dark spots and firm skin by signalling collagen. Adding it to the healing pair is meant to cover internal repair and external appearance at once, which is why this one comes up around post-surgical recovery and scarring rather than sports injuries.

GLOW with KPV added, and the addition is specifically about inflammation. KPV is the anti-inflammatory tail of a hormone called alpha-MSH, with the tanning part removed. People choose KLOW over GLOW when the skin involved is actively reactive or flaring rather than simply ageing, or when gut inflammation is in the picture too. It is the largest stack still sold as a single vial.

The two-compound version of GLOW without TB-500, and the cheapest way into this category. Run by people focused on skin and wound healing rather than tendons, since TB-500 is the member most associated with soft tissue and mobility. Often the first stack someone tries.

Two of the most discussed stacks run together, aimed at healing an injury while holding muscle during limited training.

Pairs the compound with the strongest regulatory record on this site with the most widely sold research peptide, to cover immunity and tissue repair at once.

Run by people dealing with IBD, colitis or chronic gut inflammation. BPC-157 handles the repair side, KPV the inflammation side, which is a cleaner division of labour than most stacks manage. KPV is also the rare peptide with a real argument for taking it orally: it enters cells through PepT1, a transporter that carries small peptides, and colon levels of that transporter rise when tissue is inflamed. So the target tissue pulls it in precisely when it is inflamed.

The gut pair with glutathione added, the body's own main antioxidant, which mops up molecules that damage cells. Reached for by people who connect their gut problems to toxin exposure or immune dysfunction rather than to injury or diet. Glutathione is also widely taken on its own for skin brightness, so some of its popularity here comes in sideways.

Sold as clear the bacteria then repair the lining. LL-37 is the body's own antimicrobial and BPC-157 handles the damage behind it.

Two separate appetite pathways hit at once. Semaglutide copies a gut hormone that signals fullness and steadies blood sugar. Cagrilintide copies amylin, a pancreatic hormone that slows digestion. The theory is that two fullness signals suppress appetite more than one, and the trial data supports it. Being developed as a single product by a pharmaceutical company rather than assembled by users.

The single most asked question in peptides right now. Losing weight on a GLP-1 takes muscle along with the fat, and people add ipamorelin or CJC-1295 hoping to hold onto it. Growth hormone's relationship to lean tissue is established pharmacology, so the reasoning is better than most stacks here, and the two drug classes do not interact. Sleep and recovery benefits are the secondary draw.

The CagriSema idea with retatrutide swapped in. Retatrutide acts on three receptors where semaglutide acts on one, and trial participants have seen around a quarter to nearly a third of body weight come off. Pairing it with an amylin copy is the aggressive end of appetite suppression.

Two different fat targets rather than two appetite signals. Retatrutide drives overall loss. Tesamorelin is aimed specifically at visceral fat, the deep abdominal kind that sits around organs and does not respond well to general weight loss. The mechanisms do not overlap, which is the appeal.

Retatrutide for appetite and overall loss, with AOD-9604 added on the theory that it burns fat without the muscle or blood sugar effects of full growth hormone. It is a fragment of growth hormone kept for the fat-burning part and stripped of the rest.

Aimed at a specific complaint rather than at more weight loss. Energy drops when calories are low for long enough, and MOTS-c is added for metabolic support through that stretch. It comes from mitochondria, the parts of cells that produce energy, and is run here as a support compound rather than as a weight loss agent.

Three angles at once: appetite and overall loss from retatrutide, visceral fat from tesamorelin, metabolic support from MOTS-c. The most complex stack on this page and the one where the case for medical supervision is strongest, because several members influence blood sugar and growth hormone activity at the same time.

Two drugs from the same class combined to push weight loss further, usually after a plateau. One vendor sells them premixed in a single vial.

Added to settle the gut symptoms that make people stop taking GLP-1 drugs, on the reasoning that BPC-157 protects the stomach lining.

Sold as the easy fat loss stack: a drug that suppresses appetite paired with a compound said to produce the metabolic effects of endurance training.

Added during rapid weight loss on retatrutide out of concern about loose skin, on the reasoning that GHK-Cu signals collagen.

The most established pairing in the category, run for deeper sleep, faster recovery from training and a slow shift in body composition. CJC-1295 copies GHRH, the hormone telling the pituitary to make growth hormone, and clears fast. Ipamorelin flips the ghrelin receptor, a separate switch, and triggers the pulse without much effect on hunger or stress hormones. Two different doors, which is why this pairing has lasted while others have not.

The classic growth hormone pairing with sermorelin on the first switch. Chosen for its clinical history, since sermorelin held an FDA approval and CJC-1295 never did.

The standard pair with tesamorelin added to target abdominal fat specifically. The problem is that CJC-1295 and tesamorelin are both GHRH analogs, so this is two compounds on the same switch plus one on the other. Three purchases, two mechanisms, and the third compound is largely a more expensive version of a door already open.

Aimed at training recovery and sleep, with BPC-157 covering tissue repair. MK-677 is the draw for many people because it is a once-daily pill rather than an injection. The catch is that MK-677 and GHRP-2 both act on the ghrelin receptor, so two of the three compounds are doing the same job.

The classic growth hormone pairing with tesamorelin swapped in for CJC-1295, chosen because tesamorelin is the only compound in the category with an FDA approval attached.

The advanced version of the most searched growth hormone pairing, adding IGF-1 directly rather than prompting the body to make it.

The original version of the standard growth hormone pairing, still sold premixed and still the cheapest route into the category.

Two Russian peptides from the same institute, bundled as a nootropic stack. Semax is registered there for stroke recovery and Selank for generalised anxiety.

The cognitive pair with DSIP added for the night. Poor sleep degrades focus and mood directly, so the argument is that treating daytime clarity without treating sleep is doing half the job. DSIP is taken before bed and is used to deepen sleep without the grogginess of a sedative.

Run for fatigue and brain fog rather than for anything visible. All three target mitochondria from different angles: SS-31 at the membrane where energy is generated, MOTS-c at the signalling that governs how cells respond to low energy, NAD+ as the fuel itself. NAD+ levels fall substantially with age, which is the premise the whole category rests on.

The broadest anti-ageing combination in circulation. Epitalon is taken in short courses for deeper sleep and is thought to support telomeres, the caps on chromosome ends that shorten as you age. GHK-Cu brings the visible side, skin and collagen, and BPC-157 general repair. Three levels: cellular, tissue and appearance.

Both taken before bed, both aimed at sleep quality. Epitalon is run in short courses rather than continuously, which is unusual and is the main thing to know about it. DSIP is added for sleep depth specifically.

Ageing at two levels, with the immune system as the part people forget. GHK-Cu covers skin and tissue. Thymosin alpha-1 tunes immune function and is used for chronic infections and immune resilience. The pairing appeals to people thinking about resilience rather than appearance alone.

Sold premixed as a mitochondrial or metabolic blend, aimed at energy that has dropped without an obvious cause, and at fat loss through NNMT inhibition.

Run as a sequence rather than a pair, on the argument that SS-31 repairs the mitochondrial membrane before MOTS-c signals for more capacity.

PT-141 acts on desire in the brain rather than on blood flow, and oxytocin is added for the emotional side. Sold premixed by compounding pharmacies and by vendors.

The two compounds with the most direct published human evidence for men's sexual function, paired on the argument that one works on the brain and the other on hormones.